Outcomes20

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 20 of 20

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Change From Baseline in Days Homeless Out of the Previous 6 Months as Measured at 25 Weeks	Baseline-25 weeks	26 participants were asked how many days they were homeless at week 25. Only data for these participants was analyzed for change from baseline to week 25.	days	MEAN
PRIMARY	Change From Baseline in Treatment Adherence Score as Measured at 25 Weeks	Baseline-25 weeks	17 participants were administered and completed measurement of their Treatment Adherence scores at week 25. Only data for these participants was analyzed for change from baseline to week 25.	Percentage of doses	MEAN
PRIMARY	Change From Baseline in Adherence Attitude Score as Measured by the Drug Attitude Inventory (DAI) at 25 Weeks	Baseline-25 weeks	15 participants were administered and completed measurement with the DAI at week 25. Only data for these participants was analyzed for change from baseline to week 25.	units on a scale	MEAN
PRIMARY	Change From Baseline in Treatment Adherence Behavior Score as Measured by the Morisky Medication Rating Scale at 25 Weeks	Baseline-25 weeks	16 participants were administered and completed measurement with the Morisky Medication Rating Scale at week 25. Only data for these participants was analyzed for change from baseline to week 25.	units on a scale	MEAN
PRIMARY	Change From Baseline in Adherence Attitude Score as Measured by the Attitude Toward Medication Questionnaire (AMQ) at 25 Weeks	Baseline-25 weeks	19 participants were administered and completed measurement with the AMQ at week 25. Only data for these participants was analyzed for change from baseline to week 25. Lower scores indicate improved outcomes.	units on a scale	MEAN
SECONDARY	Frequency of Health Resource Use Throughout Months 10, 11, and 12	Month 1-3, Month 10-12	Three participants were administered and completed this measurement at 12 months. Only data for these participants was analyzed for changes.	days	MEAN
SECONDARY	Change in Serious Mental Illness Severity Score as Measured by the Brief Psychiatric Rating Scale (BPRS) at 25 Weeks	Baseline-25 weeks	19 participants were administered and completed measurement with the BPRS at week 25. Only data for these participants was analyzed for change from baseline to week 25.	units on a scale	MEAN
SECONDARY	Change in Global Psychopathology as Measured by the Clinical Global Impressions (CGI) at 25 Weeks	Baseline-25 weeks	17 participants were administered and completed measurement with the DAI at week 25. Only data for these participants was analyzed for change at week 25.	units on a scale	MEAN
SECONDARY	Change in Social and Occupational Functioning Scale (SOFAS) as Measured at 25 Weeks	Baseline-25 weeks	17 participants were administered and completed measurement with the SOFAS at week 25. Only data for these participants was analyzed for change from baseline to week 25.	units on a scale	MEAN
SECONDARY	Treatment Satisfaction as Measured by the Participant Acceptability and Satisfaction Questionnaire at 25 Weeks	25 weeks	17 participants were administered and completed this measure at week 25.	units on a scale	MEAN
SECONDARY	Change in Schizophrenia and Schizoaffective Disorder Symptom Severity Scale as Measured by the Positive and Negative Syndrome Scale (PANSS) at 25 Weeks	Baseline-25 weeks	19 participants were administered and completed measurement with the PANSS at week 25. Only data for these participants was analyzed for change from baseline to week 25.	units on a scale	MEAN
SECONDARY	Frequency of Health Resource Use in the Past 3 Months as Measured at 25 Weeks	25 weeks	17 participants were administered and completed this measure at week 25.	days	MEAN
SECONDARY	Global Psychopathology as Measured by the Clinical Global Impressions (CGI) at 12 Months	12 months	12 participants were administered and completed measurement with the CGI at 12 months.	units on a scale	MEAN
SECONDARY	Change in Social and Occupational Functioning Scale (SOFAS) as Measured at 12 Months	Baseline-12 months	Six participants were administered and completed measurement with the SOFAS at 12 months. Only data for these participants was analyzed for change from baseline to 12 months.	units on a scale	MEAN
SECONDARY	Treatment Satisfaction as Measured by the Participant Acceptability and Satisfaction Questionnaire at 12 Months	12 months	Six participants were administered and completed this measure at 12 months.	units on a scale	MEAN
SECONDARY	Days Homeless Out of the Previous 6 Months as Measured at 12 Months	12 months	Six participants were administered and completed this measure at 12 months.	days	MEAN
SECONDARY	Treatment Adherence Score as Measured at 12 Months	12 months	Seven participants were administered and completed this measure at 12 months.	Percentage of doses	MEAN
SECONDARY	Adherence Attitude Score as Measured by the Drug Attitude Inventory (DAI) at 12 Months	12 months	Six participants were administered and completed this measure at 12 months.	units on a scale	MEAN
SECONDARY	Treatment Adherence Behavior Score as Measured by the Morisky Medication Rating Scale at 12 Months	12 months	Six participants were administered and completed this measure at 12 months.	units on a scale	MEAN
SECONDARY	Adherence Attitude Score as Measured by the Attitude Toward Medication Questionnaire (AMQ) at 12 Months	12 months	Seven participants were administered and completed this measure at 12 months.	units on a scale	MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01152697/outcomes

API reference For AI assistants